Back to CVE records
High 7.3HealthcarePublished Jan 21, 2022

CVE-2021-23233Fresenius Kabi Agilia Connect Infusion System

Updated under an hour ago ()

Does this affect you?

It affects Fresenius Kabi Agilia Link+ and 6 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.95%, higher than 60% of scored CVEs.

Sensitive endpoints in Fresenius Kabi Agilia Link+ v3.0 and prior can be accessed without any authentication information such as the session cookie. An attacker can send requests to sensitive endpoints as an unauthenticated user to perform critical actions or modify critical configuration parameters.

CVSS
7.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
Weakness (CWE)
CWE-284
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.95% (percentile 60)
Assigned by
icscert
NVD analysis
Modified
Record last updated
Apr 16, 2025
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Fresenius Kabi Agilia Link+
fresenius_kabi:agilia_link+ (from the name)
from unspecified before 3.0
CNA record
fresenius-kabi agilia_partner_maintenance_software
fresenius-kabi:agilia_partner_maintenance_software
through 3.3.0
NVD
fresenius-kabi vigilant_centerium
fresenius-kabi:vigilant_centerium
1.0
NVD
fresenius-kabi vigilant_insight
fresenius-kabi:vigilant_insight
1.0
NVD
fresenius-kabi vigilant_mastermed
fresenius-kabi:vigilant_mastermed
1.0
NVD
fresenius-kabi agilia_connect_firmware
fresenius-kabi:agilia_connect_firmware
through d25
NVD
fresenius-kabi link+_agilia_firmware
fresenius-kabi:link+_agilia_firmware
before 3.0; 3.0; 3.0
NVD

References

  • x-refsource-misc, third-party-advisory, us-government-resource

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.